Skip to main content

Advertisement

Table 1 Comparison of SF-36 items in patients with SSc and those with other dermatoses

From: Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses

  Number of patients Mean age (years) Median disease duration (years) Physical function Role physical Bodily pain General health Vitality Social function Role emotional Mental health
Our SSc patients 41 58 ± 13 8 (2 – 40) 66 ± 27 66 ± 43 59 ± 26 54 ± 24 54 ± 23 77 ± 25 73 ± 42 72 ± 17
Better or similar in all dimensions            
Normal population without chronic disease [14]     97 97 95 80 72 95 97 80
Patients with occupational contact dermatitis [15] 109 41 2.7 95 100 82 72 65 88 100 80
Patients with ichthyosis [16] 121 44.8   95 100 84 77 60 100 100 80
Patients with non-melanoma cervicofacial skin cancer [17] 121 63a   85 78 81 74 65 86 84 76
Patients with contact eczema [18] 38    95 100 63 72 58 88 100 70
Patients with atopic eczema [19] 70    88 76 74 65 61 83 78 75
Poorer only in mental health            
Patients with nail disorders ( >1a) [20] 72    88 76 77 65 64 77 67 65
Patients with vitiligo in China [21] 101 30.8 6.8 89 68 80 65 68 76 65 61
Health care workers with work-related skin diseases [22] 278 36.9 6.2 90 77 65 63 54 81 80 66
Chronic skin diseases [14]     80 71 69 57 54 80 74 65
Poorer in social function and mental health            
Patients with atopic dermatitis [23] 66 34.2 20.2 81 56 74 62 54 67 57 51
Patients with different types of psoriasis < 10 years [24] 380 44.3 12.4 81 62 65 64 59 62 56 58
Psoriasis ≥ 10 years [24]     77 62 60 58 56 59 54 56
Poorer or similar in all dimensions            
Patients with pemphigus vulgaris [25] 58    72 43 63 49 49 61 47 53
Patients with systemic lupus erythematosus [26] 90 40.5 10.4 50 37 54 41 41 61 56 62
  1. aMedian.
  2. Bold: SSc patients have significantly better outcomes, p < .05.
  3. Italics: SSc patients have significantly poorer outcomes, p < .05.